ESGV vs XBI
Vanguard ESG US Stock ETF vs SPDR S&P Biotech ETF
ESGV—
Vanguard ESG US Stock ETF
Broad US market with ESG screens applied.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | ESGV | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | Vanguard | State Street |
ESGV top holdings
Holdings data unavailable for ESGV.
XBI top holdings
Holdings data unavailable for XBI.
About ESGV
ESGV (Vanguard ESG US Stock ETF) is Broad US market with ESG screens applied.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.